GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Balaxi Pharmaceuticals BALAXI.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

22.66

+3.19%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Balaxi Pharmaceuticals — daily BSE:BALAXI End of day BSE listing — our prices are the NSE line

Why two exchanges. Balaxi Pharmaceuticals trades on both NSE and BSE. TradingView's free charts don't carry NSE, so the chart shows the BSE listing. The ticker and close we quote are the NSE line.

Market value
₹1.25bn
Last close × shares
Volume
16.7k
Shares, 9 Nov 2026
Price to earnings
85.3

About Balaxi Pharmaceuticals

Its shares trade on NSE under the ticker BALAXI.NS. It has been listed since 30 November 2015. In the fiscal year to 31 March 2026, it reported revenue of ₹2.73bn and net income of ₹14.2m. At that date it held total assets of ₹3.37bn and shareholders' equity of ₹2.49bn.

Balaxi Pharmaceuticals Ltd. engages in the exportation of pharmaceutical, hardware, and FMCG products. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2015-11-30. The firm is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. The company has a portfolio across multiple therapeutic segments, stock & sell models, and supplying branded and generic medicines. The firm is offerings more than 300 products across multiple therapeutic areas, including Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhoea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents and Laxative. Its consumer products include Nice 45 G, Guloso 45 G, Snax! 42 G, Doce E Sal 42 G, Yumm 75 G and Boadent.

Figures and description from our data supplier, not checked against the company's own report.

More about Balaxi Pharmaceuticals →

Latest on Balaxi Pharmaceuticals

Our reporting

We have not reported on Balaxi Pharmaceuticals yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Balaxi Pharmaceuticals's ticker?

Balaxi Pharmaceuticals trades as BALAXI.NS on NSE, under ISIN INE618N01022.

What was Balaxi Pharmaceuticals's last closing price?

22.66 on 9 Nov 2026. The figure is in INR and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.